Related Experiment Video
Updated: Jan 18, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Coronary periarteritis in IgG4-RD: A case series
Georges El Hasbani1, Daniel Larson2, Matthew J Koster3
1Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55906, USA. ElHasbani.georges@mayo.edu.
Insights
IgG4-related disease (IgG4-RD) can rarely affect coronary arteries, causing periarteritis and potential heart complications. Treatment with glucocorticoids and rituximab showed effectiveness in this case series.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Immunoglobulin G4-related disease (IgG4-RD) is a multisystemic fibroinflammatory condition.
- Coronary artery involvement in IgG4-RD, presenting as periarteritis, is uncommon.
- Coronary periarteritis can lead to serious cardiac complications, including myocardial infarction and ischemic cardiomyopathy.
Purpose of the Study:
- To characterize the clinical and radiological features of IgG4-RD-associated coronary periarteritis.
- To identify complications associated with this rare condition.
- To evaluate treatment strategies and outcomes in affected patients.
Main Methods:
- Retrospective review of electronic health records at Mayo Clinic.
- Inclusion criteria: diagnosis of IgG4-RD with confirmed coronary periarteritis.
- Analysis of clinical, laboratory, imaging, treatment, and outcome data for 9 patients.
Main Results:
- The cohort comprised 9 male patients with a mean age of 55.5 years.
- Median serum IgG-4 level was 282 mg/dL; median C-reactive protein was 10.8 mg/dL.
- CT angiography revealed coronary artery wall thickening in most cases, with two instances of aneurysm formation. Glucocorticoids and rituximab were administered. Over 7.5 years of follow-up, one patient developed ischemic heart disease and another heart failure. Seven patients showed resolution of coronary thickening.
Conclusions:
- IgG4-RD coronary periarteritis is rare but can result in aneurysms and ischemic complications.
- CT and MRI are valuable for diagnosis.
- Combined glucocorticoid and rituximab therapy appears effective, warranting further investigation for long-term outcomes.
Objectives:
IgG4-related disease (IgG4-RD) can affect multiple organ systems, with coronary artery involvement being rare. Coronary periarteritis may lead to complications such as myocardial infarction and ischemic cardiomyopathy. This case series characterizes the clinical and radiological features, complications, and treatment strategies in patients with IgG4-RD-associated coronary periarteritis.
Methods:
A retrospective review of the Mayo Clinic electronic health record identified 146 patients, of whom 9 met the inclusion criteria for IgG4-RD with coronary periarteritis. Clinical, laboratory, imaging, treatment, and outcome data were analyzed.
Results:
The cohort included 9 male patients (mean age: 55.5 ± 5.7 years). The median serum IgG-4 level was 282 mg/dL (interquartile range [IQR], 148-393), while the median C-reactive protein value was 10.8 mg/dL (IQR 7.5-53.6). The mean time from IgG4-RD diagnosis to coronary involvement was 2.5 years. CT angiography detected vessel wall thickening, affecting the right coronary artery (RCA) in five cases, the left anterior descending artery (LAD) in four, and the left main coronary artery in one. Aneurysm formation occurred in two cases. All patients received glucocorticoids, and seven were treated with rituximab. Over a mean follow-up of 7.5 years, one patient developed ischemic heart disease, and another progressed to heart failure. Repeat imaging showed partial or complete resolution of coronary thickening in seven patients.
Conclusion:
Coronary artery involvement in IgG4-RD is rare but may lead to aneurysm formation and ischemic complications. CT and MRI are valuable diagnostic tools, and rituximab with glucocorticoids appears effective, though further studies are needed. Key Points • IgG4-related disease can involve the coronary arteries, leading to periarteritis and potential complications such as myocardial infarction and aneurysm formation, highlighting the need for early recognition. • Glucocorticoids and rituximab appear to be effective in managing IgG4-RD-associated coronary periarteritis, but further studies are needed to evaluate long-term outcomes.
Related Concept Videos
Pericarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

